Electrochemiluminescence (ECL) immunosensor for detection of Francisella tularensis on screen-printed gold electrode

Anna-Maria Spehar-Délèze1, Sandra Julich2, Rainer Gransee3

  • 1Departament d'Enginyeria Quimica, Universitat Rovira i Virgili, Avinguda Països Catalans 26, 43007, Tarragona, Spain. annamaria.spehar@gmail.com.

Insights

This study presents a novel electrochemiluminescence (ECL) immunosensor for rapid Francisella tularensis detection. The assay achieved sensitive detection of bacterial cells and lipopolysaccharide (LPS) using antibody-based capture.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Immunosensing Technology

Background:

  • Francisella tularensis is a dangerous pathogen requiring rapid detection methods.
  • Existing detection techniques can be slow or lack sensitivity.
  • Development of sensitive and rapid diagnostic tools is crucial for public health.

Purpose of the Study:

  • To develop and validate an electrochemiluminescence (ECL) immunosensor for detecting Francisella tularensis.
  • To evaluate the performance of whole antibodies and antibody fragments as capture biomolecules.
  • To establish the assay's limit of detection for both bacterial cells and lipopolysaccharide (LPS).

Main Methods:

  • A sandwich immunoassay format was employed on a fluidic chip.
  • Ru(bpy)3(2+)-encapsulated silicate nanoparticles served as ECL labels conjugated to secondary antibodies.
  • Detection targeted either LPS or whole inactivated bacterial cells (LVS).

Main Results:

  • The immunosensor demonstrated rapid detection capabilities.
  • The limit of detection for LPS was 0.4 ng/mL.
  • For LVS, detection limits were 70 bacteria/mL (whole antibody) and 45 bacteria/mL (antibody F(ab) fragment).

Conclusions:

  • The developed ECL immunosensor offers a sensitive and rapid method for Francisella tularensis detection.
  • Antibody fragments showed slightly higher sensitivity compared to whole antibodies.
  • This technology holds potential for point-of-care diagnostics and biodefense applications.